COVID-19 infection under omalizumab therapy for chronic spontaneous urticaria: three cases. Ayhan E, Ozturk M, An I, BekcIbasi M, et al. Int J Dermatol 2021;60:253-254.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ayhan E, Ozturk M, An I, BekcIbasi M, et al. COVID-19 infection under omalizumab therapy for chronic spontaneous urticaria: three cases. Int J Dermatol 2021;60:253-254.
PMID: 33332576